Standout Papers

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma 2005 2026 2012 2019 6.2k
  1. Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma (2009)
    Tony Mok, Yi‐Long Wu et al. New England Journal of Medicine
  2. Erlotinib in Previously Treated Non–Small-Cell Lung Cancer (2005)
    Frances A. Shepherd, José Rodrigues Pereira et al. New England Journal of Medicine
  3. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer) (2005)
    Nick Thatcher, Alex Y. Chang et al. The Lancet
  4. Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS) (2011)
    Masahiro Fukuoka, Yi‐Long Wu et al. Journal of Clinical Oncology
  5. A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER) (2014)
    Yuankai Shi, Joseph S. K. Au et al. Journal of Thoracic Oncology
  6. Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy (2015)
    Tony Mok, Yi‐Long Wu et al. Clinical Cancer Research
  7. Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia (2013)
    Shukui Qin, Yuxian Bai et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 7 from Science/Nature 207 standout
Sub-graph 1 of 11

Citing Papers

Lung cancer
2021 Standout
Small molecules, big impact: 20 years of targeted therapy in oncology
2020 Standout
16 intermediate papers

Works of Sumitra Thongprasert being referenced

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
and 4 more

Author Peers

Author Last Decade Papers Cites
Sumitra Thongprasert 12288 14476 4311 91 18.0k
Vera Hirsh 14466 13967 4798 196 19.4k
Johan Vansteenkiste 12602 12892 4267 167 18.0k
Alan Sandler 17654 15323 5788 162 23.4k
Tudor–Eliade Ciuleanu 12498 11502 3817 198 17.0k
Sai‐Hong Ignatius Ou 11488 13702 5401 345 17.1k
Neal I. Lindeman 11485 12979 7938 166 21.9k
Lesley Seymour 13446 13259 5180 256 21.7k
Lucio Crinò 13280 13143 5395 372 19.0k
Yukito Ichinose 8610 11165 2944 227 13.7k
U. Gatzemeier 10488 12028 3552 184 15.9k

All Works

Loading papers...

Rankless by CCL
2026